Acadia Pharmaceuticals (ACAD) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -1.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01% |
| Dec 31, 2025 | 15.66% |
| Sep 30, 2025 | 18.55% |
| Jun 30, 2025 | 21.96% |
| Mar 31, 2025 | 2.04% |
| Dec 31, 2024 | 29.42% |
| Sep 30, 2024 | 17.91% |
| Jun 30, 2024 | -12.78% |
| Mar 31, 2024 | -12.39% |
| Dec 31, 2023 | -16.67% |
| Sep 30, 2023 | -39.90% |
| Jun 30, 2023 | -29.68% |
| Mar 31, 2023 | 18.90% |
| Dec 31, 2022 | -15.40% |
| Sep 30, 2022 | -26.22% |
| Jun 30, 2022 | 23.39% |
| Mar 31, 2022 | 28.07% |
| Dec 31, 2021 | 3.04% |
| Sep 30, 2021 | 13.99% |
| Jun 30, 2021 | 53.24% |
| Mar 31, 2021 | 37.81% |
| Dec 31, 2020 | 67.47% |
| Sep 30, 2020 | 58.96% |
| Jun 30, 2020 | 29.25% |
| Mar 31, 2020 | 3.22% |
| Dec 31, 2019 | 5.05% |
| Sep 30, 2019 | 35.87% |
| Jun 30, 2019 | -17.34% |
| Mar 31, 2019 | -17.73% |
| Dec 31, 2018 | 9.68% |
| Sep 30, 2018 | -3.36% |
| Jun 30, 2018 | -7.33% |
| Mar 31, 2018 | 15.03% |
| Dec 31, 2017 | 3.92% |
| Sep 30, 2017 | 45.75% |
| Jun 30, 2017 | 118.96% |
| Mar 31, 2017 | 17.73% |
| Dec 31, 2016 | 140.88% |
| Sep 30, 2016 | 135.26% |
| Jun 30, 2016 | 75.82% |
| Mar 31, 2016 | 111.82% |
| Dec 31, 2015 | 20.83% |
| Sep 30, 2015 | 106.71% |
| Jun 30, 2015 | 116.32% |
| Mar 31, 2015 | 139.57% |
| Dec 31, 2014 | 107.84% |
| Sep 30, 2014 | 63.53% |
| Jun 30, 2014 | 19.53% |
| Mar 31, 2014 | 141.73% |
| Dec 31, 2013 | 19.57% |
| Sep 30, 2013 | 6.92% |